Werth, V., Furie, R., Romero-Diaz, J., Navarra, S., Kalunian, K., Van Vollenhoven, R., Nyberg, F., Kaffenberger, B., Sheikh, S., Radunovic, G., Huang, X., Carroll, H., Gaudreault, F., Meyers, A., Barbey, C., Musselli, C., & Franchimont, N. (n.d.). oP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE). Annals of the rheumatic diseases, 79, 120–121. http://access.bl.uk/ark:/81055/vdc_100144718999.0x00003f